We narrowed to 39,907 results for: LAT;

1. Human Lipid Droplet and Metabolism Library

   Pooled Library

   #191535

   Purpose

   Lentiviral CRISPR library targeting 1,196 genes related to lipid droplet biology and cell metabolism.

   Depositor

   James Olzmann

   Article

   Roberts et al Dev Cell. 2023 Jul 18:S1534-5807(23)0033

   Expression

   Mammalian

   Use

   CRISPR and Lentiviral

   Available Since

   March 1, 2023

   Availability

   Academic Institutions and Nonprofits only

2. MoClo Plant Parts III: Transformation & Genome Engineering Kit

   Plasmid Kit

   #1000000236

   Purpose

   The MoClo Plant Parts III: Transformation & Genome Engineering Kit contains 94 Level 0 parts, compatible with the Phytobrick/MoClo system for golden gate assembly of plant transformation constructs.

   Depositor

   Daniel Voytas

   Available Since

   Feb. 21, 2024

   Availability

   Academic Institutions and Nonprofits only

3. EMMA toolkit

   Plasmid Kit

   #1000000119

   Purpose

   Used for the construction of a variety of mammalian expression vectors in a one-pot, one-step Golden Gate reaction; compatible with automated production

   Depositor

   Yizhi Cai

   Available Since

   March 1, 2018

   Availability

   Academic Institutions and Nonprofits only

4. Ubiquiton Yeast Kit

   Plasmid Kit

   #1000000243

   Purpose

   The Ubiquiton system allows the inducible, linkage-specific polyubiquitylation of a protein of interest, accommodating for linear (M1-), K48-, and K63-linkage.

   Depositor

   Helle Ulrich

   Available Since

   May 31, 2024

   Availability

   Academic Institutions and Nonprofits only

5. pAAV-GFAP104-mCherry (AAV5)

   Viral Prep

   #58909-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV-GFAP104-mCherry (#58909). In addition to the viral particles, you will also receive purified pAAV-GFAP104-mCherry plasmid DNA. GFAP104-driven mCherry expression control. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Edward Boyden

   Article

   Perea et al Nat Commun. 2014;5:3262. doi: 10.1038/nc

   Promoter

   GFAP

   Tags

   mCherry

   Available Since

   Feb. 27, 2019

   Availability

   Academic Institutions and Nonprofits only

6. pAAV-EF1a-mitoGFP-DIO (AAV2)

   Viral Prep

   #174112-AAV2

   Purpose

   Ready-to-use AAV2 particles produced from pAAV-EF1a-mitoGFP-DIO (#174112). In addition to the viral particles, you will also receive purified pAAV-EF1a-mitoGFP-DIO plasmid DNA. EF1a-driven, Cre-dependent expression of mitochondria-targeted GFP. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Maarten Kole

   Article

   Kole et al Nat Commun. 2022 Dec 9;13(1):7598. doi:

   Promoter

   EF1a

   Tags

   None

   Available Since

   Aug. 7, 2025

   Availability

   Academic Institutions and Nonprofits only

7. pAAV.hSyn.CaMPARI.WPRE.SV40 (AAV9)

   Viral Prep

   #100832-AAV9

   Purpose

   Ready-to-use AAV9 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger, Eric Schreiter

   Article

   Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

   Promoter

   Syn

   Tags

   None

   Available Since

   April 17, 2018

   Availability

   Academic Institutions and Nonprofits only

8. pAAV.hSyn.CaMPARI.WPRE.SV40 (AAV1)

   Viral Prep

   #100832-AAV1

   Purpose

   Ready-to-use AAV1 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger, Eric Schreiter

   Article

   Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

   Promoter

   Syn

   Tags

   None

   Available Since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

9. pAAV.hSyn.CaMPARI.WPRE.SV40 (AAV5)

   Viral Prep

   #100832-AAV5

   Purpose

   Ready-to-use AAV5 particles produced from pAAV.hSyn.CaMPARI.WPRE.SV40 (#100832). In addition to the viral particles, you will also receive purified pAAV.hSyn.CaMPARI.WPRE.SV40 plasmid DNA. Synapsin-driven, photoconvertible (irreversible green-to-red) calcium integrator. These AAV preparations are suitable purity for injection into animals.

   Depositor

   Loren Looger, Eric Schreiter

   Article

   Fosque et al Science. 2015 Feb 13;347(6223):755-60. d

   Promoter

   Syn

   Tags

   None

   Available Since

   April 6, 2018

   Availability

   Academic Institutions and Nonprofits only

10. pAAV-EF1a-fDIO-Cre (AAV5)

    Viral Prep

    #121675-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Esteban Engel, Alexander Nectow

    Article

    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30

    Promoter

    EF1a

    Tags

    None

    Available Since

    Sept. 27, 2024

    Availability

    Academic Institutions and Nonprofits only

11. pAAV-EF1a-fDIO-Cre (AAV1)

    Viral Prep

    #121675-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Esteban Engel, Alexander Nectow

    Article

    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30

    Promoter

    EF1a

    Tags

    None

    Available Since

    Sept. 27, 2023

    Availability

    Academic Institutions and Nonprofits only

12. pAAV-EF1a-fDIO-Cre (AAV8)

    Viral Prep

    #121675-AAV8

    Purpose

    Ready-to-use AAV8 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Esteban Engel, Alexander Nectow

    Article

    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30

    Promoter

    EF1a

    Tags

    None

    Available Since

    Dec. 15, 2020

    Availability

    Academic Institutions and Nonprofits only

13. pAAV-EF1a-fDIO-Cre (AAV9)

    Viral Prep

    #121675-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-EF1a-fDIO-Cre (#121675). In addition to the viral particles, you will also receive purified pAAV-EF1a-fDIO-Cre plasmid DNA. EF1a-driven, Flp recombinase dependent expression of Cre recombinase. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Esteban Engel, Alexander Nectow

    Article

    Schneeberger et al Cell. 2019 Jun 24. pii: S0092-8674(19)30

    Promoter

    EF1a

    Tags

    None

    Available Since

    June 4, 2019

    Availability

    Academic Institutions and Nonprofits only

14. pAAV-EF1a-Flp-DOG-NW (AAV1)

    Viral Prep

    #75469-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-Flp-DOG-NW (#75469). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flp-DOG-NW plasmid DNA. EF1a-driven expression of Flp recombinase dependent on GFP (Flp-DOG); to be coinjected with GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Connie Cepko

    Article

    Tang et al Elife. 2016 May 20;5. pii: e15312. doi:

    Promoter

    EF-1a

    Tags

    None

    Available Since

    Feb. 19, 2020

    Availability

    Academic Institutions and Nonprofits only

15. pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry (AAV1)

    Viral Prep

    #75470-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry (#75470). In addition to the viral particles, you will also receive purified pAAV-CAG-FLEXFRT-ChR2(H134R)-mCherry plasmid DNA. CAG-driven, Flp recombinase-dependent expression of channelrhodopsin H134R mutant fused to mCherry. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Connie Cepko

    Article

    Tang et al Elife. 2016 May 20;5. pii: e15312. doi:

    Promoter

    CAG

    Tags

    mCherry

    Available Since

    March 2, 2020

    Availability

    Academic Institutions and Nonprofits only

16. pAAV-hSyn-DIO-jGCaMP8s-P2A-ChrimsonR-ST (AAV9)

    Viral Prep

    #174007-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-hSyn-DIO-jGCaMP8s-P2A-ChrimsonR-ST (#174007). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-jGCaMP8s-P2A-ChrimsonR-ST plasmid DNA. Syn-driven, Cre-dependent expression of calcium sensor GCaMP8s and soma-targeted ChrimsonR. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Mark Histed

    Article

    LaFosse et al eNeuro. 2023 Mar 29;10(3):ENEURO.0378-22

    Promoter

    Syn

    Tags

    None

    Available Since

    May 4, 2023

    Availability

    Academic Institutions and Nonprofits only

17. pAAV-EF1a-C-CreintG (AAV1)

    Viral Prep

    #69571-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-C-CreintG (#69571). In addition to the viral particles, you will also receive purified pAAV-EF1a-C-CreintG plasmid DNA. EF1a-driven expression of optimized C-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-N-CretrcintG (Addgene catalog# 69570) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Connie Cepko

    Article

    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do

    Promoter

    EF1a

    Tags

    None

    Available Since

    Feb. 19, 2020

    Availability

    Academic Institutions and Nonprofits only

18. pAAV-EF1a-N-CretrcintG (AAV1)

    Viral Prep

    #69570-AAV1

    Purpose

    Ready-to-use AAV1 particles produced from pAAV-EF1a-N-CretrcintG (#69570). In addition to the viral particles, you will also receive purified pAAV-EF1a-N-CretrcintG plasmid DNA. EF1a-driven expression of optimized N-terminal component of Cre recombinase dependent on GFP (Cre-DOG OPT); to be coinjected with pAAV-EF1a-C-CreintG (Addgene catalog# 69571) and GFP (or for use with transgenic GFP animals). These AAV preparations are suitable purity for injection into animals.

    Depositor

    Connie Cepko

    Article

    Tang et al Nat Neurosci. 2015 Sep;18(9):1334-41. do

    Promoter

    EF1a

    Tags

    None

    Available Since

    Feb. 19, 2020

    Availability

    Academic Institutions and Nonprofits only

19. pAAV-Syn-ChrimsonR-tdT (AAV5)

    Viral Prep

    #59171-AAV5

    Purpose

    Ready-to-use AAV5 particles produced from pAAV-Syn-ChrimsonR-tdT (#59171). In addition to the viral particles, you will also receive purified pAAV-Syn-ChrimsonR-tdT plasmid DNA. Syn-driven ChrimsonR-tdTomato expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    Syn

    Tags

    tdTomato

    Available Since

    Feb. 7, 2018

    Availability

    Academic Institutions and Nonprofits only

20. pAAV-Syn-ChrimsonR-tdT (AAV9)

    Viral Prep

    #59171-AAV9

    Purpose

    Ready-to-use AAV9 particles produced from pAAV-Syn-ChrimsonR-tdT (#59171). In addition to the viral particles, you will also receive purified pAAV-Syn-ChrimsonR-tdT plasmid DNA. Syn-driven ChrimsonR-tdTomato expression for optogenetic neural activation. These AAV preparations are suitable purity for injection into animals.

    Depositor

    Edward Boyden

    Article

    Klapoetke et al Nat Methods. 2014 Mar;11(3):338-46. doi:

    Promoter

    Syn

    Tags

    tdTomato

    Available Since

    Feb. 7, 2018

    Availability

    Academic Institutions and Nonprofits only